Shelf-life and its estimation in drug stability studies
Shelf-life and its estimation in drug stability studies
One important property of any drug product is its stability over time. Drug stability studies are routinely carried out in the pharmaceutical industry in order to measure the degradation of an active pharmaceutical ingredient of a drug product. One important study objective is to estimate the shelf-life of the drug; the estimated shelf-life is required by the US Food and Drug Administration to be printed on the package label of the drug. This involves a suitable definition of the true shelf-life and the construction of an appropriate estimate of the true shelf-life. In this paper, the true shelf-life T? is defined as the time point at which 100?% of all the individual dosage units (e.g. tablets) of the drug have the active ingredient content no less than the lowest acceptable limit L, where ? and L are prespecified constants. The value of T? depends on the parameters of the assumed degradation model of the active ingredient content and so is unknown. A lower confidence bound Tˆ? for T? is then provided and used as the estimated shelf-life of the drug.
1989-2000
Liu, W.
b64150aa-d935-4209-804d-24c1b97e024a
Hsu, J.C.
b5fdbac8-26f4-4ac2-a009-c49a7bef5c51
Bretz, F.
51270819-e491-4a72-a410-679d86231e64
Hayter, A.J.
55bd07a5-db1d-4d3d-8c87-b307485420d9
Han, Y.
8cd0ca3e-648a-4c0f-904c-4f353ba9ebdb
24 March 2014
Liu, W.
b64150aa-d935-4209-804d-24c1b97e024a
Hsu, J.C.
b5fdbac8-26f4-4ac2-a009-c49a7bef5c51
Bretz, F.
51270819-e491-4a72-a410-679d86231e64
Hayter, A.J.
55bd07a5-db1d-4d3d-8c87-b307485420d9
Han, Y.
8cd0ca3e-648a-4c0f-904c-4f353ba9ebdb
Liu, W., Hsu, J.C., Bretz, F., Hayter, A.J. and Han, Y.
(2014)
Shelf-life and its estimation in drug stability studies.
Journal of Applied Statistics, 41 (9), .
(doi:10.1080/02664763.2014.898135).
Abstract
One important property of any drug product is its stability over time. Drug stability studies are routinely carried out in the pharmaceutical industry in order to measure the degradation of an active pharmaceutical ingredient of a drug product. One important study objective is to estimate the shelf-life of the drug; the estimated shelf-life is required by the US Food and Drug Administration to be printed on the package label of the drug. This involves a suitable definition of the true shelf-life and the construction of an appropriate estimate of the true shelf-life. In this paper, the true shelf-life T? is defined as the time point at which 100?% of all the individual dosage units (e.g. tablets) of the drug have the active ingredient content no less than the lowest acceptable limit L, where ? and L are prespecified constants. The value of T? depends on the parameters of the assumed degradation model of the active ingredient content and so is unknown. A lower confidence bound Tˆ? for T? is then provided and used as the estimated shelf-life of the drug.
This record has no associated files available for download.
More information
Published date: 24 March 2014
Organisations:
Statistics
Identifiers
Local EPrints ID: 369888
URI: http://eprints.soton.ac.uk/id/eprint/369888
ISSN: 0266-4763
PURE UUID: 8d1fbb87-c83f-438b-beaa-a90cc3b5746f
Catalogue record
Date deposited: 08 Oct 2014 10:48
Last modified: 15 Mar 2024 02:43
Export record
Altmetrics
Contributors
Author:
J.C. Hsu
Author:
F. Bretz
Author:
A.J. Hayter
Author:
Y. Han
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics